000 | 03522nam a22004453a 4500 | ||
---|---|---|---|
005 | 20150712005455.0 | ||
008 | 950321s1994 enk||||| 00||0 eng d | ||
010 | _agb 94080538 | ||
020 | _a0851864945 | ||
020 | _a0851864945 (pbk.) | ||
040 |
_aCaOON _beng _cCaOON |
||
050 | 4 |
_aRS403 _b.M38 1994 |
|
050 | 4 |
_aRS403 _b.M44 1994 |
|
060 | 0 | 0 | _a1994 K-866 |
060 | 1 | 0 |
_aQV 744 _bM4894 1994 |
060 | 4 |
_aRS403 _b.M38 1994 |
|
082 | _a615.19 | ||
084 |
_a615.19 _bK M |
||
100 | 1 | _aKing, Frank D. | |
245 | 1 | 0 |
_aMedicinal chemistry _h[Book :] _bprinciples and practice / _cedited by Frank D. King. |
260 |
_aCambridge [England] : _bRoyal Society of Chemistry, _cc1994. |
||
300 |
_axxi, 313 p. : _bill. ; _c24 cm. |
||
500 | _aLectures presented at the 7th RSC Medicinal Chemistry School held June 28th-July 3rd 1993, at the University of Kent, Canterbury, UK.--Cf. pref. | ||
504 | _aIncludes bibliographical references and subject index. | ||
505 | 0 | _aCh. 1. An Introduction to Drug-Receptor Interactions / Barry Hunt -- Ch. 2. Signal Transduction and Second Messengers / Trevor J. Franklin -- Ch. 3. Enzyme Inhibitors / David A. Roberts -- Ch. 4. The Biological Evaluation of New Compounds / Robert A. Coleman -- Ch. 5. Pharmacokinetics / Robert M. J. Ings -- Ch. 6. Drug Metabolism / Colin Vose -- Ch. 7. Physicochemical Properties and Drug Design / Nigel P. Gensmantel -- Ch. 8. Quantitative Structure - Activity Relationships / Andrew M. Davis -- Ch. 9. Considerations for the Use of Computational Chemistry Techniques by Medicinal Chemists / Mike M. Hann -- Ch. 10. 'Patent Medicine' / Bill Tyrrell -- Ch. 11. Molecular Biology - A New Route to Drug Discovery / Janet E. Carey -- Ch. 12. Devising a Research Strategy / Colin W. Greengrass -- Ch. 13. Past Approaches to Discovering New Drugs as Medicines / C. Robin Ganellin. | |
505 | 8 | _aCh. 14. Bioisosteres, Conformational Restriction and Pro-drugs: Approaches to Lead Optimisation - Case History: An Example of a Conformational Restriction Approach / Frank D. King -- Ch. 15. The Design and Synthesis of Selective Protein Kinase C Inhibitors / Christopher H. Hill -- Ch. 16. Discovery of 1069C - A Novel Synthetic Antitumour Agent with Low Cross-Resistance Potential / Simon T. Hodgson -- Ch. 17. The Design and Biological Properties of 'Dipeptoid' Antagonists / David C. Horwell -- Ch. 18. Migraine Therapy - from Serotonin to Sumatriptan / Peter C. North -- Ch. 19. Drug Development / Jane Ormerod -- App. 1. Summary of Receptor Properties -- App. 2. Summary of Ion Channel Properties -- App. 3. Enzyme Commission Classification of Enzymes -- App. 4. Schematic Representations of Mechanisms of Proteases -- App. 5. Table of Substituent Constant [pi], MR, F, R, and [sigma] -- App. 6. An Example of a Craig Diagram Plot of [sigma] vs. [pi]. | |
505 | 8 | _aApp. 7. Summary of Common Routes of Administration -- App. 8. Approximate Conversion Factors for [Delta]log to Ratio -- App. 9. Conversion Factors for Solutions and Dosages: Molar vs. Weight. | |
521 | _aAll Ages. | ||
650 | 0 | _aPharmaceutical chemistry. | |
650 | 1 | 2 |
_aChemistry, Pharmaceutical _xcongresses. |
650 | 6 |
_aChimie pharmaceutique _xCongr?es. |
|
650 | 4 |
_aPharmaceutical chemistry _xCongresses. |
|
700 | 1 | 0 | _aKing, Frank D. |
710 | 2 | 0 | _aRoyal Society of Chemistry (Great Britain) |
711 | 2 | 0 |
_aRSC Medicinal Chemistry School _n(7th : _d1993 : _cCanterbury, England) |
990 | 1 | 0 |
_a91001a _b71001a |
001 | 0000032687 | ||
003 | 0000 | ||
942 | _cBK | ||
999 |
_c52236 _d52236 |